Sawada T, Kidowaki T, Sugimoto T, Kusunoki T
Med Pediatr Oncol. 1984;12(2):101-3. doi: 10.1002/mpo.2950120208.
Since 1974, we have been mass screening for neuroblastoma in 6-month-old infants using a VMA (vanilmandelic acid) spot test in Kyoto City. Fifteen (48.4%) of the 31 childhood neuroblastoma cases registered in this city during the recent 8-year-period, 1974-1982, were under 1 year of age. The annual number of cases per year was 3.9 cases under 15 years with 1.9 cases under 1 year of age. As the number of children under 15 years of age in this city was 292,000 according to the National Census of the Human Population in 1975, the annual incidence of this tumor in childhood was 3.9/292,000 (13.3/million). And as the number of live births was 161,153, the annual detection rate for this tumor in infancy increased to 15/161,153 (93/million) from 1974 to 1982. We found that many neuroblastomas could be detected in infancy by a VMA spot test and/or a careful physical examination.
自1974年以来,我们一直在京都对6个月大的婴儿进行大规模神经母细胞瘤筛查,采用香草扁桃酸(VMA)斑点试验。在1974年至1982年最近8年期间,该市登记的31例儿童神经母细胞瘤病例中,有15例(48.4%)年龄在1岁以下。每年15岁以下的病例数为3.9例,其中1岁以下的病例数为1.9例。根据1975年全国人口普查,该市15岁以下儿童数量为292,000人,因此该肿瘤在儿童期的年发病率为3.9/292,000(13.3/百万)。由于活产数为161,153,1974年至1982年期间该肿瘤在婴儿期的年检出率增至15/161,153(93/百万)。我们发现,通过VMA斑点试验和/或仔细的体格检查,可以在婴儿期检测出许多神经母细胞瘤。